NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
04/04/2023
Back to search
Official data from USPTO
OSNA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000088022705Class
5, 9, 10, 42, 44
Filing
88022705
Registration
6868542
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
68
Latest update
04/28/2023
Trademark type
Combined
Nice classes
5, 9, 10, 42, 44
Filing date
07/02/2018
Registration date
10/11/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2022
Last transaction
04/28/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
03
Owner location
Kobe, Hyogo, JP
Examiner
REEVES, APRIL ELIZABETH
Law office
N60
Current location
TMO LAW OFFICE 124
Mark description
The mark consists of a black square with rounded corners having the white letters "OSNA" and two white intertwining lines that project from the lower left corner of the square to the right side of the square.
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Virginia Wolk Marino CROWELL & MORING
Technical classification
Nice Classes
Class 5Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or veterinary purposes; chemical reagents and chemical preparations for medical or pharmaceutical purposesreagents for detecting metastasis of cancer; testing reagents and preparations for medical or veterinary purposes; pharmaceutical preparations for in vitro diagnosis; reagents for medical usereagents for genetic test; reagents for medical usereagents for amplification and detection of genes; reagents for medical uselymph node solubilizing reagents; reagents for medical usereagents for protein test; reagents for medical usereagents for cancer recurrence prediction test; reagents for medical usereagents for anticancer drug sensitivity prediction test; diluents for medical or veterinary purposes; diluents for medical or clinical diagnostic use; diluents for genetic test for medical or clinical diagnostic use; reference control materials for medical use; quality control standard solutions and quality control reagents for testing and calibrating medical apparatus and reagents
Class 9
Gene amplification or detection device for scientific or research usefor detecting metastasis of cancer; laboratory apparatus and instrumentsfor genetic testing for scientific and research purposes; measuring or testing machines and instruments for analyzing bloodbody fluidtissue or other biological samples not for medical purposes
Class 10
Diagnostic apparatus and instruments for medical purposesfor testing DNA or RNA; diagnostic or measuring apparatus and instruments for medical purposes in the nature of genetic testing apparatus and instrumentsgene amplification detectorcancer metastasis analyzercell cycle analyzercancer recurrence prediction testing apparatus and instrumentsanticancer drug sensitivity prediction testing apparatus and instrumentssample transfer apparatussample container transfer apparatussample rack transfer apparatus; measuring apparatus and instruments for medical purposes for analyzing genes; pipettes for medical purposes; containers for samples for in vitro diagnosis; sampling bottles for medical purposes
Class 42
Medical or scientific research on cancer diagnosis; medical research; providing information relating to medical research; testingexamination or research of reagents and other medicines; testingexamination or research of medical apparatus and instruments and other machines; technological advice relating to medical apparatus and instrumentslaboratory apparatus and instrumentsmeasuring or testing machines and instrumentstesting apparatus and instrumentscomputers and other machines; rental of gene amplification or detection device for scientific or research use; rental of laboratory apparatus and instruments; rental of measuring or testing machines and instruments for medical or scientific research; all of the foregoing for use with medical and scientific research in the field of cancer diagnosis
Class 44
Clinical genetic testing for detecting metastasis of cancer for diagnostic or treatment purposes; clinical testing of genes in lymph node for medical purposes; providing information relating clinical testinggenetic testing; medical analysis and evaluation of clinical laboratory tests results for diagnosis of cancer metastasis or other diseases; providing medical information in the field of genetic testing; rental of medical apparatus and instruments
Publications
History of USPTO decisions and trademark events.
68 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
03/02/2023
XXXX
POST REGISTRATION ACTION CORRECTION
02/03/2023
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
02/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/20/2022
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
12/20/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/28/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/11/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/11/2022
CHPN
POST PUBLICATION AMENDMENT – NOT ENTERED
10/08/2022
APET
ASSIGNED TO PETITION STAFF
10/04/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
09/19/2022
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/08/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/12/2022
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
08/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/03/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/03/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
08/01/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/28/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
07/28/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/17/2022
EX5G
SOU EXTENSION 5 GRANTED
02/16/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/16/2022
EXT5
SOU EXTENSION 5 FILED
02/09/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/21/2021
EX4G
SOU EXTENSION 4 GRANTED
08/19/2021
EXT4
SOU EXTENSION 4 FILED
08/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/19/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/18/2021
EX3G
SOU EXTENSION 3 GRANTED
02/16/2021
EXT3
SOU EXTENSION 3 FILED
02/16/2021
EEXT
SOU TEAS EXTENSION RECEIVED
02/16/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/28/2020
EX2G
SOU EXTENSION 2 GRANTED
08/26/2020
EXT2
SOU EXTENSION 2 FILED
08/26/2020
EEXT
SOU TEAS EXTENSION RECEIVED
08/26/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/28/2020
EX1G
SOU EXTENSION 1 GRANTED
01/24/2020
EXT1
SOU EXTENSION 1 FILED
01/24/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/24/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
10/08/2019
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/25/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/16/2019
PUBO
PUBLISHED FOR OPPOSITION
07/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/26/2019
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/10/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/10/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/06/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/08/2019
GNFR
FINAL REFUSAL E-MAILED
05/08/2019
CNFR
FINAL REFUSAL WRITTEN
05/08/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2019
ALIE
ASSIGNED TO LIE
04/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/03/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/09/2018
GNRT
NON-FINAL ACTION E-MAILED
10/09/2018
CNRT
NON-FINAL ACTION WRITTEN
10/09/2018
DOCK
ASSIGNED TO EXAMINER
09/25/2018
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/07/2018
NWAP
NEW APPLICATION ENTERED
07/05/2018
Continuous trademark protection
Get notified about every new filing that threatens OSNA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.